MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Gastroenterology

Section

Gastroenterology

642 articles

Ask AI
All specialtiesGastroenterologynewsClinical UpdatesCardiologyOncology

Latest updates

Gastroenterology

AASLD EXPO 2026: Modern Role and Recommendations for Liver Biopsy

An expert-practice summary of the 2026 AASLD EXPO on liver biopsy: indications, techniques (percutaneous, transjugular, EUS-guided), sample adequacy, safety thresholds, and emerging applications including molecular profiling and digital pat

Oct 22, 2026
Diabetes & Endocrinology

Saroglitazar Shows Promise in Treating Hepatic Steatosis in Women with PCOS and MASLD: Insights from a Multicenter Trial

Saroglitazar significantly improves liver fat content, liver enzymes, and lipid profiles in women with PCOS and MASLD, highlighting its potential as a therapeutic option in this underrepresented population.

Oct 21, 2026
Gastroenterology

Long-term Outcomes of Neoadjuvant Nivolumab and Ipilimumab in MSI-High Gastric and GEJ Adenocarcinoma: Insights from the Phase 2 NEONIPIGA Trial

The NEONIPIGA phase 2 trial demonstrates durable survival and high pathological complete response rates with neoadjuvant nivolumab and ipilimumab in localized MSI-high gastric and GEJ adenocarcinoma, highlighting potential for organ-preserv

Oct 21, 2026
Gastroenterology

Shortening Sofosbuvir-Velpatasvir Therapy for Non-Cirrhotic Chronic Hepatitis C: Evidence from the RESOLVE Trial in India

The RESOLVE trial demonstrates that 8 weeks of sofosbuvir-velpatasvir treatment is non-inferior to the standard 12-week regimen in treatment-naive, non-cirrhotic chronic hepatitis C patients, supporting shorter treatment duration without co

Oct 21, 2026
Gastroenterology

Reevaluating EASL 2025 Criteria: Benefits of Nucleos(t)ide Analogues in Chronic Hepatitis B Beyond Current Recommendations

This study demonstrates that nucleos(t)ide analogue therapy significantly reduces cirrhosis and hepatocellular carcinoma risk in specific HBeAg-positive chronic HBV infection phases beyond current EASL 2025 treatment indications.

Oct 20, 2026
Allergy & Immunology

Phase 2 Trial of Icotrokinra for Patients with Ulcerative Colitis

This phase 2b trial demonstrates that oral icotrokinra, targeting the interleukin-23 receptor, significantly improves clinical outcomes in moderate to severe ulcerative colitis compared to placebo.

Oct 20, 2026
Infectious Diseases

Dynamic Immune Modulation by Pegylated Interferon-Alpha Post-NUC Withdrawal in Chronic Hepatitis B

Pegylated interferon-alpha after nucleos(t)ide analog withdrawal induces coordinated expansion of regulatory B cells and contraction of HBV-specific T cells, impacting viral control and hepatic inflammation in HBeAg-negative chronic hepatit

Oct 19, 2026
Gastroenterology

Identifying Preclinical Crohn’s Disease in High-Risk Individuals Using Faecal Calprotectin: A New Framework for Prevention Trials

A study in asymptomatic first-degree relatives of Crohn’s disease patients defines preclinical stages using faecal calprotectin, offering a targeted screening approach to enrich prevention trial cohorts.

Oct 19, 2026
Gastroenterology

PREBOTPilot Trial: Botulinum Toxin Injection Into the Sphincter of Oddi Fails to Prevent Pancreatic Fistula After Distal Pancreatectomy

A randomized controlled trial showed that preoperative botulinum toxin injection into the sphincter of Oddi does not reduce the incidence of clinically relevant postoperative pancreatic fistula following distal pancreatectomy.

Oct 18, 2026
Gastroenterology

Unveiling the Role of HtpG-High-Expressing Escherichia coli in Chronic Pancreatitis Fibrosis: Microbiota-Targeted Therapeutic Hope

Identification of a pathogenic E. coli strain overexpressing HtpG that promotes fibrosis in chronic pancreatitis via macrophage-mediated pathways highlights new microbiota-targeted treatment avenues.

Oct 18, 2026
Gastroenterology

Impact of Donor Warm Ischemic Time on Biliary Complications After Laparoscopic Donor Right Hepatectomy: Insights From a Retrospective Cohort Study

Prolonged donor warm ischemia during pure laparoscopic donor right hepatectomy elevates recipient biliary stricture risk, underscoring the need to minimize warm ischemic time for better post-transplant outcomes.

Oct 17, 2026
Gastroenterology

Targeting IMPDH2-Induced Guanine Nucleotide Depletion to Enhance KRAS Inhibition in Pancreatic Cancer

An integrated genomic and pharmacologic analysis identifies IMPDH2 as a key vulnerability in KRAS-mutant pancreatic cancer, showing that irreversible guanine nucleotide depletion potentiates KRAS-targeted therapies and offers a novel combin

Oct 17, 2026
Gastroenterology

Zinc-Dependent RNA Binding Protein ZFP36L1: A Key Regulator of Hepatocyte Senescence and Alcohol-Related Liver Disease Recovery

This article explores how the zinc-dependent RNA-binding protein ZFP36L1 controls hepatocyte senescence and influences recovery from alcohol-related liver failure by modulating key mRNAs, highlighting its potential as a therapeutic target i

Oct 16, 2026
Gastroenterology

How the 2026 Chinese Consensus Changes Use of Immune Checkpoint Inhibitors in Locally Advanced Rectal Cancer

The Chinese Society of Colorectal Surgery consensus (Gut 2026) standardizes use of immune checkpoint inhibitors (ICIs) in locally advanced rectal cancer—diagnostics, perioperative strategies, organ preservation, safety and follow-up.

Oct 15, 2026
Diabetes & Endocrinology

Optimizing Insulin Therapy with Continuous Glucose Monitoring in Nocturnal Parenteral Nutrition Patients

Continuous glucose monitoring-guided insulin optimization improves glycemic control and nutritional status in insulin-treated adults receiving long-term nocturnal parenteral nutrition, reducing hyperglycemia and associated complications.

Oct 15, 2026
Gastroenterology

MTFP1 and Metabolic Reprogramming: Unlocking New Targets in Pancreatic Cancer Liver Metastasis

MTFP1 promotes pancreatic ductal adenocarcinoma liver metastasis by enhancing mitochondrial oxidative phosphorylation via the ROS/PI3K/AKT/c-MYC/SLC1A5 axis, revealing a promising therapeutic target to reverse tumor immune suppression and r

Oct 14, 2026Sign in to read
Gastroenterology

Assessing Survival Outcomes of Simultaneous Liver-Kidney Versus Liver Alone Transplantation in the Era of the 2017 OPTN Policy

This analysis of over 63,000 US liver transplants reveals that simultaneous liver-kidney transplantation (SLKT) confers significant survival benefit only in patients with severe renal dysfunction (eGFR <30), with no advantage in those wi

Oct 13, 2026Sign in to read
Gastroenterology

Evaluating Surgical Skill Impact on Delayed Gastric Emptying After Robotic Pancreatoduodenectomy

This study identifies a learning curve in robotic gastroenterostomy during robotic pancreatoduodenectomy and shows that better surgical performance reduces delayed gastric emptying risk, suggesting OSATS scoring as a valuable training tool.

Oct 13, 2026Sign in to read
Gastroenterology

Disrupted Microbial Metabolism in Gut Inflammation as a Key Driver of Adverse Food Reactions in IBD

Intestinal inflammation disrupts gut microbial metabolism of dietary antigens, promoting food sensitization and mast cell–mediated adverse reactions, which may explain frequent food intolerances in IBD patients.

Oct 13, 2026Sign in to read
Gastroenterology

Outcomes and Mortality After Pediatric First Variceal Hemorrhage: Insights from a Global Multicenter Study

This international multicenter study reveals low immediate mortality after pediatric first variceal hemorrhage, with outcomes strongly influenced by underlying diagnosis, disease severity, and center-specific practices.

Oct 12, 2026
Previous
2 / 25
1234…25
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.